image
Exelixis, Inc. EXEL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 38.69
2.76 %
$ 10.8 B
Market Cap
21.98
P/E
INCOME STATEMENT
2.17 B REVENUE
18.49%
Growth Rates
1Year 18.49%
3Years 14.76%
5Years 17.51%
7Years 25.09%
10Years 56.18%
605 M OPERATING INCOME
253.82%
Growth Rates
1Year 253.82%
3Years 28.24%
5Years 10.35%
7Years 20.29%
10Years 16.72%
521 M NET INCOME
150.89%
Growth Rates
1Year 150.89%
3Years 31.15%
5Years 10.18%
7Years 19.00%
10Years 14.70%
EFFICIENCY
Earnings Waterfall Exelixis, Inc.
image
Revenue 2.17 B
Cost Of Revenue 0
Gross Profit 2.17 B
Operating Expenses 1.56 B
Operating Income 605 M
Other Expenses 83.4 M
Net Income 521 M

Income Statement

Millions
Jan-2025 Dec-2023 Dec-2022 Dec-2021 Jan-2021 Jan-2020 Dec-2018 Dec-2017 Dec-2016 Jan-2016 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Jan-2010 Jan-2009 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
REVENUE
Revenue 2 168.7 1 830.2 1 611.1 1 435.0 987.5 967.8 853.8 452.5 191.5 37.2 25.1 31.3 47.5 289.6 185.0 151.8 117.9 113.5 98.7 76.0 52.9 51.5 44.3 41.0 24.8 10.5 2.3
GROSS PROFIT
Cost Of Revenue 0 72.5 57.9 52.9 36.3 33.1 26.3 15.1 6.6 3.9 2.0 1.1 0 0 0 0 0 0.2 0.8 1.1 0.8 0 0 0 (18.6) (5.7) 0
Gross Profit 2 168.7 1 757.7 1 553.2 1 382.1 951.3 934.7 827.5 437.4 184.9 33.3 23.1 30.2 47.5 289.6 185.0 151.8 117.9 113.3 97.8 74.9 52.1 51.5 44.3 41.0 43.4 16.2 2.3
OPERATING INCOME
Operating Expenses 1 564.1 1 586.8 1 351.7 1 095.4 841.2 565.2 388.6 271.5 212.1 153.7 239.9 229.7 160.7 190.0 243.7 273.7 298.9 307.5 225.4 170.0 159.4 146.9 131.4 109.6 86.2 35.0 17.6
Selling, General and Administrative Expenses 492.1 542.7 459.9 401.7 293.4 228.2 206.4 159.4 116.1 57.3 50.8 51.0 31.8 33.1 33.0 39.0 36.9 44.9 39.1 27.7 20.9 18.6 18.8 19.2 18.9 7.6 5.5
Research and Development Expenses 910.4 1 044.1 891.8 693.7 547.9 337.0 182.3 112.2 96.0 96.4 189.1 178.8 128.9 156.8 210.7 234.7 257.4 225.4 185.5 141.1 137.7 127.6 112.0 82.7 48.5 21.7 12.1
Operating Income 604.6 170.9 201.5 286.7 110.1 369.5 438.9 165.9 (28.1) (121.4) (224.5) (200.7) (122.4) 89.5 (91.4) (121.9) (179.3) (157.0) (126.8) (94.0) (135.2) (96.3) (87.8) (75.3) (42.9) (18.8) (15.3)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0 0 8.7 33.1 48.7 48.6 45.3 27.1 16.3 9.3 12.7 6.8 0 0 0 0 0 0 0 0 0 0
Total Other Income 77.0 86.6 32.9 7.5 20.8 28.6 13.2 (7.3) (42.1) (40.3) (44.3) (44.1) (25.1) (12.5) (1.0) (18.9) 3.7 46.0 25.3 (0.8) (2.0) 1.1 3.3 (9.4) (38.1) 0 (0.4)
Pre-Tax Income 681.6 257.5 234.4 294.2 130.8 398.1 452.1 158.6 (70.2) (169.7) (268.7) (244.9) (147.5) 77.0 (92.4) (140.8) (162.9) (86.4) (101.5) (94.8) (137.2) (95.1) (84.5) (84.7) (81.0) 0 (15.7)
NET INCOME
Tax Provision 160.4 49.8 52.1 63.1 19.1 77.1 (238.0) 4.3 32.1 55 K (0.2) 96 K 0.1 1.3 72 K (1.3) (18.1) (107.6) 0 (9.6) 30.7 (0.3) 0.3 2.5 32.4 100 K 0
Net Income 521.3 207.8 182.3 231.1 111.8 321.0 690.1 154.2 (70.2) (169.7) (268.5) (244.8) (147.6) 75.7 (92.3) (135.2) (162.9) (86.4) (101.5) (84.4) (137.2) (94.8) (86.1) (71.2) (75.3) (18.7) (15.7)
EPS 1.8 0.65 0.57 0.73 0.36 1.06 2.32 0.52 0.28 0.81 1.38 1.33 0.92 0.6 0.85 1.26 1.54 0.87 1.17 1.07 1.89 1.45 1.52 1.53 2.43 4.6 7.88